medicalxpress - Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and coordinator of powerful immune hubs that form inside tumors and plays a key role in antitumor immunity. This discovery could lead to …
AI Summary: Researchers discovered a subset of dendritic cells that orchestrate formation and maintenance of tertiary lymphoid structures—local immune “hubs”—inside tumours. These niches concentrate and sustain anti-tumour T cells, explaining how some cancers spontaneously marshal immune responses and opening avenues to boost immunotherapy by enhancing or mimicking this dendritic cell-driven architecture.
Mass spectrometry platform could cut drug discovery to hours / 2 months
Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity / 5 months
Merck and Moderna report positive phase‑3 melanoma vaccine results / 14 days
Belzutifan plus lenvatinib outperforms cabozantinib in advanced RCC / 15 days
First patient enrolled in AACR-ADOPT-GEA gastroesophageal cancer trial / 25 days
Mass release of next‑generation tumor organoids accelerates research / 26 days
Phase 1 trial shows cevostamab activity in relapsed multiple myeloma / 5 wks
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.